{
  "symbol": "NGNE",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": ["biotechnology sector", "small-cap company", "gene therapy focus"],
    "riskScore": 8,
    "reason": "Neurogene Inc. operates in the biotechnology sector, focusing on gene therapy, which is prone to speculative interest. As a small-cap company, it is more susceptible to retail-driven price movements."
  }
}